DUBLIN--(BUSINESS WIRE)--The "Inferior Vena Cava Filters Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
The inferior vena cava filters market was valued at US$502.35 million in 2017 and is expected to reach US$825.02 million by 2023 growing at a CAGR of 8.62% during the forecast period.
Factors driving the inferior vena cava filter are high increased research and development expenditures, growth in the cardiac devices market, rising healthcare spending in emerging economies and technology spill over in nascent markets. Geographically, North America and Europe dominate the IVC filters market while Asia Pacific is a region of high growth.
In industry overview section, the entire inferior vena cava filters market is explained along with the various drivers, restraints and opportunities. A product pipeline has been mentioned along with innovations in the market. Certain regulations specific to the industry are also listed out, followed by a detailed scenario analysis.
The competitive intelligence section deals with major players in the market, their market shares, products, growth strategies, financials, and recent investments among others.
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Inferior Vena Cava Filters Industry Overview
5. Inferior Vena Cava Filters Market Forecast by Type (US$ million)
6. Inferior Vena Cava Filters Market Forecast by Geography (US$ million)
7. Competitive Intelligence
8. Company Profiles
- Liberator Medical Holdings, Inc (ALN)
- B. Braun
- Boston Scientific
- C.R. Bard
- Cook Medical
- J&J (Cordis Corporation)
For more information about this report visit https://www.researchandmarkets.com/research/cdtj38/global_inferior?w=4